Glioblastoma Multiforme Therapeutics Market

The global Glioblastoma Multiforme Therapeutics market was valued at US$ 564.1 million in 2022 and is projected to reach US$ 990.5 million by 2029, at a CAGR of 8.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Glioblastoma multiforme is the most aggressive variant of malignant brain cancer. It has a poor prognosis with low rate of survival, a median of one year. The primary brain tumor happens due to uncontrolled cell division and developments in the brain. The tumors can be found in the glial cells or the neuron. The one which develops in the glial cells (astrocytes and oligodendrocytes) is called glioma, the commonest forms of brain tumor.
Glioblastoma Multiforme Therapeutics Market aims to provide a comprehensive presentation of the global market for Glioblastoma Multiforme Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glioblastoma Multiforme Therapeutics. Glioblastoma Multiforme Therapeutics Market contains market size and forecasts of Glioblastoma Multiforme Therapeutics in global, including the following market information:

• Global Glioblastoma Multiforme Therapeutics Market Revenue, 2018-2023, 2024-2029, ($ millions)
• Global Glioblastoma Multiforme Therapeutics Market Sales, 2018-2023, 2024-2029, (K Units)
• Global top five Glioblastoma Multiforme Therapeutics companies in 2022 (%)

Currently unavailable therapies and prognosis for the treatment of GBM is expected to impact the market growth positively through to 2022. Presence of the treatment options which do not increase the overall survival rate in patients such as surgical resection, which is followed by chemotherapy and radiotherapy, is another factor attributing towards the expected growth of this market. Moreover, the fact that glioma stem cells resist conventional treatments also raises urgent need for alternative treatment therapies for glioblastoma multiforme thus driving the market. Increasing R&D in gene therapy and molecular biotechnology for the treatment of CNS associated disorders and cancer is anticipated to fuel the market growth over the forecast period. However, high expenditure involved in research employing genomics based research is a key restraint for market.
We surveyed the Glioblastoma Multiforme Therapeutics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Glioblastoma Multiforme Therapeutics Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Glioblastoma Multiforme Therapeutics Market Segment Percentages, by Type, 2022 (%)

• Temozolomide
• Bevacozumab
• Carmustine

Global Glioblastoma Multiforme Therapeutics Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Glioblastoma Multiforme Therapeutics Market Segment Percentages, by Application, 2022 (%)

• Hospitals
• Clinics
• Others

Global Glioblastoma Multiforme Therapeutics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Glioblastoma Multiforme Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Glioblastoma Multiforme Therapeutics revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Glioblastoma Multiforme Therapeutics revenues share in global market, 2022 (%)
Key companies Glioblastoma Multiforme Therapeutics sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Glioblastoma Multiforme Therapeutics sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:

• Arbor Pharmaceuticals
• Bristol-Myers Squibb
• Eisai
• F. Hoffmann-La Roche
• Merck

Outline of Major Chapters:

• Chapter 1: Introduces the definition of Glioblastoma Multiforme Therapeutics, market overview.
• Chapter 2: Global Glioblastoma Multiforme Therapeutics market size in revenue and volume.
• Chapter 3: Detailed analysis of Glioblastoma Multiforme Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
• Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
• Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
• Chapter 6: Sales of Glioblastoma Multiforme Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
• Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
• Chapter 8: Global Glioblastoma Multiforme Therapeutics capacity by region & country.
• Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
• Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
• Chapter 11: The main points and conclusions of the report.

To know more about market statistics, Download a FREE Sample copy